Lasik, Cornea & Cataract Specialty Center offers
Keratoconus Cross-Linking

Lasik, Cornea & Cataract Speciality Center is excited to offer the cross-linking procedure using Avedro KXL system, the ONLY FDA approved cross linking device.  For more information about cost and the procedure please call 915-261-7011.

or call: 915-261-7011

What does corneal cross-linking mean for me?

In April 2016, the FDA approved Photrexa Visccous (riboflavin 5'-phosphate sodium in 20% dextran opthalmic solution) and Photrexa (riboflavin 5'-phosphate sodium opthalmic solution) the KKL System for corneal cross-linking, a minimally invasive outpatient procedure that combines the use of Vitamin B2 eye drops and ultra-violet (UV) light.

Corneal cross-linking stiffens corneas that have been weakened by disease. They are the first and only therapeutic products for corneal cross-linking which have been FDA approved to treat progressive keratoconus, and we offer them to patients in our practice.

The approval of Photrexa Viscous, Photrexa and the KXL System offers an effective treatment for patients who, until recently, had no therapeutic options to limit the progression of the sight-threatening disease.

Corneal cross-linking with Photrexa Viscous, Photrexa and the KXL System


What can I expect during the procedure?

  • After numbing drops are applied, the epithelium (the thin layer on the surface of the cornea) is gently removed.
  • Photrexa Viscous eye drops will be applied to the cornea for at least 30 min;
  • Depending on the thickness of your cornea, Photrexa drops may also be required.
  • The cornea is then exposed to UV light for 30 minutes while additional Photrexa Viscous drops are applied.

What can I expect after the procedure?

  • You should not rub your eyes for the first five days after the procedure.
  • You may notice a sensitivity to light and have a foreign body sensation. You may also experience discomfort in the treated eye and sunglasses may help with light sensitivity.
  • If you experience severe pain in the eye or any sudden decrease in vision, you should contact your physician immeidately.
  • If your bandage contact lens from the day of the treatment falls out or becomes dislodged, you should not replace it and contact your physician immediately.

What is keratoconus?

This image is for illustrative purpose only, keratoconus affects both eyes but each eye may be affected differently, and patients may experience different vision problems.

Keratoconus, often referred to as ‘KC’, is a non-inflammatory eye condition in which the typically round dome-shaped cornea progressively thins and weakens, causing the development of a cone-like bulge and optical irregularity of the cornea. This causes ‘static’ in your vision and can result in significant visual loss and may lead to corneal transplant in severe cases.

A rare condition, keratoconus typically first appears in individuals who are in their late teens or early twenties.


  • Can result in significant visual loss; and
  • May lead to corneal transplant in severe cases.

Summary of Information About Corneal Cross-Linking

What is corneal cross-linking?

  • Corneal cross-linking is a minimally invasive outpatient procedure that combines the use of Photrexa Viscous (riboflavin 5'-phosphate in 20% dextran opthalmic solution), Photrexa (riboflavin 5'-phosphate opthalmic solution) and KXL system for the treatment of progressive keratoconus.
  • The safety and effectiveness of corneal cross-linking has not been established in pregnant women, women who are breastfeeding, patients who are less than 14 years of age and patients 65 years of age or older.

What warnings should I know about corneal cross-linking?

  • Ulcerative keratitis, a potentially serious eye infection, can occur.
  • Your doctor should monitor you for resolution of epithelial defects if they occur.

What are the side effects corneal cross-linking?

  • The most common ocular adverse reactions in any corneal cross-linked eye were haze (corneal opacity), inflammation (punctate keratitis), fine white lines (corneal striae), disruption of surface cells (corenal epithelium defect), eye pain, reduced sharpness of vision (visual acuity) blurred vision.

The risk information provided here is not comprehensive. To learn more, talk about corneal cross-linking with your health provider.

The FDA-approved product labeling can be found at You are encouraged to report negative side effects of prescription drugs to the FDA.  Visit MedWatch (/Safety/MedWatch/default.htm) or call 1-800-FDA-1088.

Photrexa Viscous, Photrexa, and the KXL System are available for sale in the United States. All other Avedro products and procedures are not available in the United States. 

or call: 915-261-7011

What Our Patients Have to Say

Best eye Doctor ever. Very professional and friendly staff. They are always happy to see me. Makes me feel safe when I'm there with them. I got a cornea transplant and it has been a very successful surgery. It feels as if I was reborn... Thank you so much Dr. Di Pascuale and staff!! :)

Cyndi Sandoval

Amazing staff, state of the art equipment. Great job everyone and thank you for fast and friendly service.

Cynthia Ponce

Our Medical Team









Make Your Appointment Today

After you have sent us your request, our scheduling staff will contact you to schedule your appointment. To request an appointment by telephone during office hours, please call Monday-Friday, 7:30 a.m. to 5:30 p.m.

or call: 915-261-7011


Copyright © 2018 Lasik, Cornea & Cataract Specialty Center. All rights reserved. Website optimized by Lasik, Cornea & Cataract Specialty Center. Disclaimer: The information contained within this eye care website is not intended to be taken as medical advice. The information provided by Lasik, Cornea & Cataract Specialty Center is intended to provide general information regarding LASIK, cataract, laser surgery, glaucoma treatment, medical retina problems and more to El Paso and throughout the nearby areas. If you are interested in finding out more, please contact us today for a personal consultation.